Pembrolizumab plus chemotherapy in triple-negative breast cancer – Authors' reply

Publication date: 3–9 July 2021Source: The Lancet, Volume 398, Issue 10294Author(s): Javier Cortes, Hope S Rugo, Zifang Guo, Vassiliki Karantza, Peter Schmid
Source: The Lancet - Category: General Medicine Source Type: research